A Case of Esophageal Candidiasis in an Adolescent Who Had Frequently Received Budesonide Nebulizing Therapy.
10.5223/pghn.2013.16.3.185
- Author:
Hae Ryong KANG
1
;
Yong Hoon KWON
;
Yong Joo KIM
Author Information
1. Department of Pediatrics, Hanyang University College of Medicine, Seoul, Korea. kyjoo@hanyang.ac.kr
- Publication Type:Case Report
- Keywords:
Esophagus;
Candidiasis;
Budesonide;
Nebulizers
- MeSH:
Adolescent;
Adrenal Cortex Hormones;
Budesonide;
Candidiasis;
Child;
Cough;
Deglutition Disorders;
Endoscopy;
Esophagus;
Humans;
Hyphae;
Mucous Membrane;
Nebulizers and Vaporizers;
Seasons
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2013;16(3):185-189
- CountryRepublic of Korea
- Language:English
-
Abstract:
Corticosteroid (budesonide) nebulizer therapy is commonly performed. Its side effects have been considered as being safe or ignorable. The authors present a case of esophageal candidiasis in a healthy female adolescent who was treated with budesonide nebulizer therapy a few times for a cough during the previous winter season. This child presented with dysphagia and epigastric pain for 1 month. Esophageal endoscopy showed a whitish creamy pseudomembrane and erosions on the esophageal mucosa. Pathologic findings showed numerous candidal hyphae. She did not show any evidence of immunodeficiency, clinically and historically. The esophageal lesion did not resolve naturally. The esophageal lesion completely improved with the antifungal therapy for 2 weeks; the symptoms disappeared, and the patient returned to normal health. It is important that frequent esophageal exposure to topical corticosteroids application can cause unexpected side effects.
